Sign In
Not register? Register Now!
Pages:
2 pages/≈550 words
Sources:
3 Sources
Style:
APA
Subject:
Health, Medicine, Nursing
Type:
Essay
Language:
English (U.S.)
Document:
MS Word
Date:
Total cost:
$ 9.72
Topic:

Pharmacotherapy in Major Depressive Disorder

Essay Instructions:

How does an advanced practice nurse determine the best treatment option or pharmacotherapeutic to recommend for patients with psychological disorders?
Much like assessing or recommending pharmacotherapeutics for other conditions or disorders, as an advanced practice nurse, you may encounter a patient who presents with a psychological disorder. Understanding the guiding principles related to treating patients with psychological disorders as well as the effects of pharmacotherapeutics on a patient’s overall health and well-being is critical for the safe and effective delivery of care.
This week, you examine types of drugs prescribed to patients with psychological disorders. You also examine potential impacts of pharmacotherapeutics used to treat psychological disorders on a patient’s pathophysiology.
Learning Objectives
Students will:
Evaluate patients for treatment of psychological disorders
Analyze decisions made throughout the diagnosis and treatment of patients with psychological disorders
Analyze impacts of pharmacotherapeutics for psychological disorders on patient pathophysiology
Evaluate patients for treatment of neurological and musculoskeletal disorders
Analyze decisions made throughout the diagnosis and treatment of patients with neurological and musculoskeletal disorders
Justify decisions made throughout the diagnosis and treatment of patients with neurological and musculoskeletal disorders
Learning Resources
Required Readings (click to expand/reduce)
Rosenthal, L. D., & Burchum, J. R. (2018). Lehne’s pharmacotherapeutics for advanced practice providers. St. Louis, MO: Elsevier.
Chapter 24, “Antipsychotic Agents and Their Use in Schizophrenia” (pp. 231–246)
Chapter 25, “Antidepressants” (pp. 247–265)
Chapter 26, “Drugs for Bipolar Disorder” (pp. 267–274)
Chapter 27, “Sedative-Hypnotic Drugs” (pp. 275–285)
Chapter 28, “Management of Anxiety Disorders” (pp. 287–292)
Chapter 29, “Central Nervous System Stimulants and Attention-Deficit/Hyperactivity Disorder” (pp. 293–299)
Required Media (click to expand/reduce)
Laureate Education (Producer). (2019a). Adult geriatric depression [Interactive media file]. Baltimore, MD: Author.

In this interactive media piece, you will engage in a set of decisions for prescribing and recommending pharmacotherapeutics to treat adult geriatric depression.
Laureate Education (Producer). (2019c). Attention deficit hyperactivity disorder [Interactive media file]. Baltimore, MD: Author.

In this interactive media piece, you will engage in a set of decisions for prescribing and recommending pharmacotherapeutics to treat attention deficit hyperactivity disorder.
Laureate Education (Producer). (2019d). Bipolar therapy [Interactive media file]. Baltimore, MD: Author.

In this interactive media piece, you will engage in a set of decisions for prescribing and recommending pharmacotherapeutics for bipolar therapy.
Laureate Education (Producer). (2019g). Generalized anxiety disorder [Interactive media file]. Baltimore, MD: Author.

In this interactive media piece, you will engage in a set of decisions for prescribing and recommending pharmacotherapeutics to treat generalized anxiety disorder.
Discussion: Decision Making When Treating Psychological Disorders
Psychological disorders, such as depression, bipolar, and anxiety disorders can present several complications for patients of all ages. These disorders affect patients physically and emotionally, potentially impacting judgment, school and/or job performance, and relationships with family and friends. Since these disorders have many drastic effects on patients’ lives, it is important for advanced practice nurses to effectively manage patient care. With patient factors and medical history in mind, it is the advanced practice nurse’s responsibility to ensure the safe and effective diagnosis, treatment, and education of patients with psychological disorders.
Photo Credit: Getty Images/iStockphoto
For this Discussion, you will select an interactive media piece to practice decision making when treating patients with psychological disorders. You will recommend the most effective pharmacotherapeutic to treat the psychological disorder presented and examine potential impacts of pharmacotherapeutics on a patient’s pathophysiology.
To Prepare
Review this week’s interactive media pieces and select one to focus on for this Discussion.
Reflect on the decision steps in the interactive media pieces, and consider the potential impacts from the administration of the associated pharmacotherapeutics on the patient’s pathophysiology

Essay Sample Content Preview:

Decision Making When Treating Depression
Your Name
Subject and Section
Professor’s Name
Date of Submission
Pharmacotherapy in Major Depressive Disorder
There are three primary treatment regimens for depression, namely, pharmacotherapy, depression-specific psychotherapy, and somatic therapy. Drug therapy or psychotherapy is proven effective for mild to moderate depression, while the combination of the two is the best treatment for severe depression (Rosenthal & Burchum, 2018).
Drug Selection
Insomnia is a sleep disorder characterized by the difficulty in inducing sleep or staying asleep. This can be acute, which lasts from one night to a few weeks, or chronic, wherein the difficulty happens at least thrice a week for at least three consecutive months (Morin, Drake, Harvey, et al., 2015). In the case given, the patient has had insomnia for approximately six months. Thus, an antidepressant that is suitable for the patient is the atypical antidepressant, Mirtazapine (Rosenthal & Burchum, 2018).
It has also been stated in the case that the patient is suffering from poor concentration, which hinders him from working effectively and weight gain for the past few months (Rosenthal & Burchum, 2018).
Atypical Antidepressant: Mirtazapine
Mirtazapine is an atypical antidepressant with a generic name of Remeron. It belongs to the first-line treatment regimens for major depressive disorder (Rosenthal & Burchum, 2018).
Its mechanism of action is to block the presynaptic a2-adrenergic receptors. Thus, inhibiting adrenergic effects and promoting neurotransmitter release, namely 5-hydroxytryptamine (5-HT2 and 5-HT3) and norepinephrine. Furthermore, this has been found to inhibit histamine release by blocking histamine receptors. Hence, promoting sedation and weight gain (Rosenthal & Burchum, 2018)....
Updated on
Get the Whole Paper!
Not exactly what you need?
Do you need a custom essay? Order right now:

You Might Also Like Other Topics Related to schizophrenia essays:

HIRE A WRITER FROM $11.95 / PAGE
ORDER WITH 15% DISCOUNT!